Free. Unsubscribe any time.
CG Oncology, Inc. (CGON)
CG Oncology, Inc. filed 23 Form 4 statements naming a Rule 10b5-1 trading plan in the 2025 filing year, by 2 reporting owners, covering 30 transactions and 145,197 shares. 22 carry the SEC's AFF10B5ONE flag; 1 name a plan only in a footnote. 7 results prints are on file in the same window.
What stands out
- The most recent filing on file, dated 2026-08-18, came 32 days after the one before it (2026-07-17) and reports 3 transactions against 3 in the filing before it.
- The sales it reports total 1,000 shares, the same as the 1,000 in the filing before it.
- Its 23 plan statements rank 260th of the 483 companies the register carries in Delaware, its state of incorporation.
- Of the 10 companies the register lists beside it in its industry, 3 have more plan statements on file than it, 6 have fewer and 1 has the same number.
- Its 23 filings on file run from 2025-01-14 to 2026-08-18, and state 4 plan adoption dates, from 2024-09-06 to 2026-03-27.
Trades in CG Oncology, Inc. 30
- POST LEONARD E — 2025-01-13 · S · 1,000 shares
- POST LEONARD E — 2025-02-18 · S · 1,000 shares
- POST LEONARD E — 2025-03-17 · S · 1,000 shares
- POST LEONARD E — 2025-04-28 · S · 1,000 shares
- POST LEONARD E — 2025-05-21 · S · 1,000 shares
- POST LEONARD E — 2025-09-03 · S · 1,000 shares
- Mulay James — 2025-09-05 · S · 12,342 shares
- Mulay James — 2025-09-05 · S · 4,095 shares
- Mulay James — 2025-09-05 · S · 7,465 shares
- Mulay James — 2025-09-05 · S · 3,113 shares
- POST LEONARD E — 2025-09-15 · S · 1,000 shares
- Mulay James — 2025-09-18 · S · 19,112 shares
Adoption dates in CG Oncology, Inc. 4
- 2024-09-06 — stated in 9 filings
- 2025-06-06 — stated in 7 filings
- 2026-03-05 — stated in 5 filings
- 2026-03-27 — stated in 2 filings
Results prints in CG Oncology, Inc. 7
- 2025-03-28
- 2025-05-13
- 2025-08-08
- 2025-11-14
- 2026-02-27
- 2026-05-08
- 2026-08-06
Trades before a print in CG Oncology, Inc. 0
- 11 days before the 2025-03-28 print — 2025-03-17 · S · POST LEONARD E · 1,000 shares
- 15 days before the 2025-05-13 print — 2025-04-28 · S · POST LEONARD E · 1,000 shares
- 21 days before the 2026-05-08 print — 2026-04-17 · S · Mulay James · 15,600 shares
- 22 days before the 2026-08-06 print — 2026-07-15 · S · POST LEONARD E · 1,000 shares
- 27 days before the 2026-08-06 print — 2026-07-10 · S · Mulay James · 24,165 shares
- 32 days before the 2025-11-14 print — 2025-10-13 · S · POST LEONARD E · 1,000 shares
- 36 days before the 2025-11-14 print — 2025-10-09 · S · Mulay James · 5,903 shares
- 38 days before the 2025-03-28 print — 2025-02-18 · S · POST LEONARD E · 1,000 shares
- 43 days before the 2026-08-06 print — 2026-06-24 · S · POST LEONARD E · 5,000 shares
- 45 days before the 2026-08-06 print — 2026-06-22 · S · POST LEONARD E · 5,000 shares
- 46 days before the 2025-11-14 print — 2025-09-29 · S · Mulay James · 12,755 shares
- 49 days before the 2026-02-27 print — 2026-01-09 · S · Mulay James · 654 shares
Interval to CG Oncology, Inc.’s next reported results date
How the interval and sources are counted →
- 0within 5 days
- 0within 10 days
- 11shortest, days
- 1no later print
Adoption dates CG Oncology, Inc. states
- 2024-09-06 in 9 filings
- 2025-06-06 in 7 filings
- 2026-03-05 in 5 filings
- 2026-03-27 in 2 filings
Filing text: “10b5-1 trading plan adopted by the Reporting Person on September 6, 2024”
Reported results dates on file
- 2025-03-28
- 2025-05-13
- 2025-08-08
- 2025-11-14
- 2026-02-27
- 2026-05-08
- 2026-08-06
A proxy statement is on file for this company in the same window, which is where a company states its own trading policy.
Other companies with plan records
- BRISTOL MYERS SQUIBB CO 2
- FMC CORP 2
- ELI LILLY & Co 11
- ABEONA THERAPEUTICS INC. 7
- HEXCEL CORP /DE/ 2
- TEVA PHARMACEUTICAL INDUSTRIES LTD 37
- Lifevantage Corp 3
- IONIS PHARMACEUTICALS INC 86
- VERTEX PHARMACEUTICALS INC / MA 74
- ARROWHEAD PHARMACEUTICALS, INC. 23
Sources: SEC EDGAR full-text search and the SEC submissions API.